5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

NCT04689347 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Bevacizumab
DRUG: Irinotecan
DRUG: Leucovorin
DRUG: 5Fluorouracil
DRUG: Temozolomide

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano